Does BROMAZEPAM Cause Interstitial lung disease? 35 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Interstitial lung disease have been filed in association with BROMAZEPAM. This represents 0.6% of all adverse event reports for BROMAZEPAM.
35
Reports of Interstitial lung disease with BROMAZEPAM
0.6%
of all BROMAZEPAM reports
1
Deaths
20
Hospitalizations
How Dangerous Is Interstitial lung disease From BROMAZEPAM?
Of the 35 reports, 1 (2.9%) resulted in death, 20 (57.1%) required hospitalization, and 16 (45.7%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BROMAZEPAM. However, 35 reports have been filed with the FAERS database.
What Other Side Effects Does BROMAZEPAM Cause?
Drug abuse (964)
Toxicity to various agents (914)
Coma (790)
Somnolence (641)
Intentional overdose (467)
Poisoning deliberate (419)
Fall (385)
Hypotension (375)
Drug use disorder (351)
Suicide attempt (345)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which BROMAZEPAM Alternatives Have Lower Interstitial lung disease Risk?
BROMAZEPAM vs BROMFENAC
BROMAZEPAM vs BROMHEXINE
BROMAZEPAM vs BROMOCRIPTINE
BROMAZEPAM vs BROTIZOLAM
BROMAZEPAM vs BUCILLAMINE